LUTETIUM LU-177: 114 Adverse Event Reports & Safety Profile

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

114

Total FAERS Reports

13 (11.4%)

Deaths Reported

Hospitalizations

114

As Primary/Secondary Suspect

Life-Threatening

Disabilities

First Report: 200807 · Latest Report: 20241228

What Are the Most Common LUTETIUM LU-177 Side Effects?

#1 Most Reported

Malignant neoplasm progression

39 reports (34.2%)

#2 Most Reported

Fatigue

35 reports (30.7%)

#3 Most Reported

Diarrhoea

29 reports (25.4%)

Side Effect	Reports	% of Total	Deaths	Hosp.
Malignant neoplasm progression	39	34.2%	6	21
Fatigue	35	30.7%	2	17
Diarrhoea	29	25.4%	3	18
Abdominal pain	19	16.7%	1	11
Asthenia	19	16.7%	1	16
Vomiting	19	16.7%	2	14
Blood pressure increased	18	15.8%	1	10
Body temperature decreased	18	15.8%	0	11
Drug ineffective	18	15.8%	2	0
Blood pressure systolic increased	17	14.9%	0	12
Nausea	17	14.9%	2	15
Pain	17	14.9%	2	8
Back pain	16	14.0%	2	13
Dizziness	16	14.0%	1	14
Alopecia	14	12.3%	0	8
Decreased appetite	14	12.3%	2	9
Malaise	14	12.3%	0	13
Metastases to liver	14	12.3%	1	7
Nasopharyngitis	14	12.3%	1	9
Arthralgia	13	11.4%	0	11

Gender: 27.6% female, 72.4% male. Average age: 66.4 years. Most reports from: CA. View detailed demographics →

Year	Reports	Deaths	Hosp.
2008	1	1	1
2010	1	0	1
2011	3	1	3
2012	3	1	1
2013	1	0	1
2014	5	1	4
2015	6	1	4
2016	5	0	2
2017	11	0	0
2018	3	1	2
2019	8	0	0
2020	2	0	0
2021	1	0	1
2022	2	0	1
2023	2	0	0
2024	2	1	2

Indication	Reports
Product used for unknown indication	50
Prostate cancer	16
Hormone-refractory prostate cancer	14
Prostate cancer metastatic	12

Official prescribing information from the FDA-approved drug label.